Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Acticor Biotech

Acticor Biotech
2013 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series B LATEST DEAL TYPE
$24.7M LATEST DEAL AMOUNT
10 INVESTORS
Description

Developer of an antithrombotic agent for the treatment of the acute phase of ischemic stroke. The company's biologic drug candidate ACT017 is a humanized fragment of monoclonal antibody which binds to GPVI and inhibits platelet adhesion and aggregation on collagen and polymerized fibrin.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Hôpital Bichat-INSERM U1148
  • 46, rue Henri Huchard
  • 75018 Paris
  • France

+33 09 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Acticor Biotech’s full profile, request a free trial.

Acticor Biotech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series B) 06-Nov-2019 $24.7M 000.00 000.00 Completed Clinical Trials - Phase 2
4. Early Stage VC 20-Dec-2017 00.000 00.000 000.00 Completed Startup
3. Early Stage VC 07-Feb-2017 00.000 00.000 00.000 Completed Pre-Clinical Trials
2. Seed Round 26-Jan-2015 $782K $782K 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Acticor Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
ABSA 000,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Preference 00,000 00.000000 000.00 000.00 00 000.00 0.000
Preference 28,037 $1.108602 $60.97 $60.97 1x $60.97 9.77%
Ordinary 17,552 $1.108602 $42.13 $42.13 1x $42.13 6.12%
To view this company’s complete Cap Table, request access »

Acticor Biotech Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dendreon Corporate Backed or Acquired Seal Beach, CA 000 00.000 000000&0
000000 00000000000 Failed Transaction (M&A) Cambridge, MA 000 00000 000000&0
00000000 000000000 Formerly VC-backed Houston, TX 000 00000 000000000000 00000
0000000 0000000000 Venture Capital-Backed San Diego, CA 00 00000 00000000
0000000 0000000000 Corporation San Diego, CA 00 00000 000000000 00000
To view this company’s complete list of competitors, request access »

Acticor Biotech Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 06-Nov-2019 000000000000000000 Diagnostic Equipment 000000 0000000 00
To view this company’s complete investment and acquisition history, request access »

Acticor Biotech Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
A&B (HK) Company Corporation Minority 000 0000 000000 0
Anaxago Real Estate Minority 000 0000 000000 0
China Medical System Corporation Minority 000 0000 000000 0
Go Capital PE/Buyout Minority 000 0000 000000 0
Mirae Asset Venture Investment PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Acticor Biotech Executive Team (4)

Name Title Board
Seat
Contact
Info
Olivier Favre-Bulle Ph.D Chief Operating Officer
Gilles Avenard MD Co-Founder, President, Chief Executive Officer & Board Member

2 Former Executives

You’re viewing 2 of 4 executives. Get the full list »

Acticor Biotech Board Members (9)

Name Representing Role Since Contact
Info
Catherine Boule CapDecisif Management Board Member 000 0000
Christophe Pasik Acticor Biotech Board Member 000 0000
Gilles Avenard MD Acticor Biotech Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Jean Pierre Cazenave MD Acticor Biotech Board Member 000 0000
Joachim Dupont Acticor Biotech Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »